Serum levels of resistin and hsCRP in women with PCOS

ÇAPOĞLU İ., Erdem F., Uyanik A., Turhan H.

CENTRAL EUROPEAN JOURNAL OF MEDICINE, cilt.4, sa.4, ss.428-432, 2009 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 4 Sayı: 4
  • Basım Tarihi: 2009
  • Doi Numarası: 10.2478/s11536-009-0071-0
  • Dergi Adı: CENTRAL EUROPEAN JOURNAL OF MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.428-432
  • Anahtar Kelimeler: Resistin, hsCRP, PCOS, POLYCYSTIC-OVARY-SYNDROME, C-REACTIVE PROTEIN, INSULIN-RESISTANCE, METABOLIC SYNDROME, OBESITY, EXPRESSION, PREVALENCE, INFLAMMATION, MACROPHAGES
  • Atatürk Üniversitesi Adresli: Evet

Özet

Resistin has been associated with obesity and type 2 diabetes. The elevated serum resistin level in human diabetes is often associated with a pro-inflammatory milieu. In vitro data suggest that C-reactive protein (CRP) significantly increases resistin expression in cultured human PBMC, yet the relationship in vivo is largely unknown. The purpose of this study was to determine the concentrations of CRP and resistin in women with polycystic ovary syndrome (PCOS) and to clarify whether or not there are correlations between CRP and resistin levels that have not previously been studied in PCOS in the context of resistin. Serum resistin and hsCRP levels of forty-five women with PCOS were analyzed. Compared with the control group, women with PCOS had significantly higher serum concentrations of resistin (p=0.009). Women with PCOS had higher hsCRP levels compared with controls, but these differences were not statistically significant (p>0.05). There was no correlation between serum resistin and hsCRP levels (r=0.128, p=0.404). Our study suggests that resistin concentrations was not associated with hsCRP levels